Hydrogen Treatment and Endometrial Cancer Cells in Lab Studies
RNA sequencing analysis reveals apoptosis induction by hydrogen treatment in endometrial cancer via TNF and NF-κB pathways
Research hubs: Reproductive System
This research was done on cells or tissue in a lab, not in people or animals.
- Evidence type
- Laboratory study (cells or tissue)
- Authors
- Ye Yang, Yin-Ping Liu, Wei Bao, Jun-Song Chen, Xiao-Wei Xi
- Journal
- Translational Cancer Research
- Year
- 2020
- PMID
- 35117712
- Study Type
- Cell Culture
- Delivery
- Water (Dissolved)
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 8 (OpenAlex, as of November 2026)
- Country
- China
TL;DR
Hydrogen treatment may help fight endometrial cancer by triggering cell death pathways.
Key Finding
Hydrogen treatment increased the rate of apoptosis (cell death) in three types of endometrial cancer cells by activating TNF and NF-κB signaling pathways.
Summary
Researchers tested whether hydrogen (dissolved in water) could affect endometrial cancer cells grown in laboratory dishes. They used genetic analysis to track how hydrogen changed the cells' behavior and found that hydrogen treatment triggered a process called apoptosis (programmed cell death) by activating specific cellular pathways involved in cell death signals.
Practical Takeaway
This is early laboratory research in cancer cells only—not humans or animals. While the results are interesting, they cannot yet tell us whether hydrogen water would have any effect on endometrial cancer in people. Much more research, including animal studies and eventually human trials, would be needed before any therapeutic claims could be considered.
Abstract (excerpt)
Background: To evaluate the activity of hydrogen in endometrial cancer and elucidate its underlying molecular mechanisms. Methods: Ishikawa, HEC1A and AN3CA cells were incubated in DMEM medium with or without hydrogen. RNA sequencing was used to explore the association of hydrogen treatment…